Emily Vogtmann, PhD, MPH

Emily Vogtmann, Ph.D., M.P.H., is a Research Fellow in the Metabolic Epidemiology Branch of the Division of Cancer Epidemiology & Genetics at the National Cancer Institute. She has a B.S. in Biochemistry and Molecular Biology from Michigan State University, an M.P.H. in International Health Epidemiology from the University of Michigan, and a Ph.D. in Epidemiology from the University of Alabama at Birmingham.
Dr. Vogtmann’s program of epidemiologic research focuses on the association between the human microbiome and cancer, with a particular emphasis on gastrointestinal cancers. She has completed numerous studies evaluating methods to optimize biosample collection, handling, bioinformatics, and statistics.
She is a member of the multi-institutional MicroBiome Quality Control project (www.mbqc.org) that is evaluating the reproducibility of microbiome measurement methods, particularly the impact of protocols for DNA extraction, PCR amplification, 16S rRNA sequencing, and bioinformatic data processing.
Dr. Vogtmann is currently launching several new population-based studies that will allow new comprehensive assessments of the role of the human microbiota in gastrointestinal cancers.